Arvinas vs SEED Therapeutics

Arvinas logo

Arvinas

Leading the way in targeted protein degradation therapeutics

305 employees · est. 2013 · New Haven, United States

VS
SEED Therapeutics logo

SEED Therapeutics

Pioneering the science of improving human health

25 employees · est. 2019 · New York, United States

Arvinas is the older company (2013 vs 2019); Arvinas is the larger of the two.

Side-by-Side Comparison

Arvinas SEED Therapeutics
Founded
2013 older 2019
Headquarters
New Haven, United States New York, United States
Employees
305 larger 25
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage
Not tracked yet Series A
Total Funding
$585.85M $65.40M
Funding Rounds
6 4
Taxonomy
BiopharmaceuticalProtein DegradationTherapeuticsClinical-stageDisease TreatmentPROTAC® Discovery Engine Platform +9 Not tracked yet
Website
arvinas.com seedtherapeutics.com
Arvinas logo

About Arvinas

Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the aim of improving the lives of patients suffering from debilitating and life-threatening diseases. Th...

SEED Therapeutics logo

About SEED Therapeutics

Seed Therapeutics is a biotechnology company founded in 2019 with a focus on improving human health through the creation of "molecular glues." These innovative therapeutics aim to degrade disease-causing proteins that were previously considered "undruggable." The company collaborates with renowned a...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Arvinas and SEED Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Arvinas or SEED Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Arvinas was founded in 2013, based in New Haven, United States, with 305 employees. Arvinas is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in the United States. The company is committed to developing targeted protein degradation therapeutics with the. SEED Therapeutics was founded in 2019, based in New York, United States, with 25 employees. Seed Therapeutics is a biotechnology company founded in 2019 with a focus on improving human health through the creation of "molecular glues." These innovative therapeutics aim to degrade disease-caus.
Arvinas has raised $585.85M and SEED Therapeutics $65.40M. Latest stage: SEED Therapeutics Series A.
Both work in Biotechnology, Health and Wellness and Pharmaceutical.

Compare Arvinas with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arvinas on 9 Jun 2026, and SEED Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes